Blackrock Neurotech
Advancing BCI with MoveAgain
The Challenge
In partnership with Blackrock Neurotech, the global leader in BCI and creator of the Utah Array, the only FDA-approved implanted BCI device on the market, AE Studio supported the development of MoveAgain, a groundbreaking system designed to restore movement for patients with paralysis.
The Result
AE's data science team built and refined the software and analytics platform powering the device, conducting deep data analysis to improve in-session signal collection, decoder performance, and clinical usability.
Key Features
High-performance data analysis to optimize signal decoding and enhance motor intention interpretation
Clinical data confidentiality & compliance ensuring adherence to strict FDA and HIPAA standards
Collaborative research workflow integrating directly with Blackrock's neuroscience and engineering teams to validate models and findings
Iterative optimization process accelerating performance tuning for use in active clinical trials
Last updated: Dec 2025
Ready to build something amazing?
Let's discuss how we can help transform your ideas into reality.